Imunon, Inc. fell 12.5% on Tuesday, November 10, 2026, on 243,700 shares. No headline about IMNN came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
Imunon, Inc. (IMNN:NASDAQ) closed at $0.594 on November 16, 2026, down 5.56% on the day. The stock trades 86.3% below its 52-week high of $4.35 and 18.8% above its 52-week low of $0.500. Over the past year, it lost 85.5%. Imunon, Inc. is part of the Health Care sector.
In 252 trading sessions since November 14, 2025, IMNN closed higher on 86 days (34%). Its best day was October 21, 2026 (+17.82%) and its worst was October 27, 2026 (-28.46%). The stock moved 10% or more in a single session 5 times. It opened at least 5% above the previous day's high 2 times.
Celsion Corp is active in the biotechnology sector. The company acts as a drug developer with product candidates like ThermoDox, a heat-activated liposomal encapsulation of doxorubicin. It is in a clinical trial for the treatment of primary liver cancer. Its pipeline also includes GEN-1, a deoxyribonucleic acid (DNA) mediated immunotherapy for the localized treatment of ovarian and brain cancers.
Find more stocks like IMNN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.